A Phase 2 interventional study of wheat polysaccharides and maltodextrin in Upper Respiratory Infections and Common Cold, sponsored by Clinical Research Center Kiel GmbH. Completed at 1 site in Germany. Open to participants aged 50 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-04-12.
Sponsored by Clinical Research Center Kiel GmbH · Phase 2, Interventional, and Prevention
The aim of the study is to measure the effect of wheat polysaccharides on the occurence of common cold (CC) in elderly during a 12-week consumption period.
The study is conducted in the frame of the collaborative project 'FibeBiotics' (No. 289517) (Fibers as support of the Gut and Immune function of Elderly - From polysaccharide compound to health Claim) within the Seventh Framework Programme (FP7) for Research and Technological Development of the European Union (EU).
6,687 studies on the registry are indexed under Infections; 807 are open to participants now.
This study's enrollment of 247 is above the median of 120 across 4,200 interventional studies indexed under Infections.
Browse Infections studies →Clinical Research Center Kiel GmbH is the lead sponsor of 7 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
12.0 g powder containing 10.0 g active ingredient (wheat polysaccharides) as well as 2.0 g filling substance (maltodextrin) stirred in milk or filtered apple juice (200 ml each).
Dietary Supplement: wheat polysaccharides
12.0 g maltodextrin stirred in milk or filtered apple juice (200 ml each).
Dietary Supplement: maltodextrin
Consumed once daily for 12 weeks.
Consumed once daily for 12 weeks.
Occurrence of common cold (CC) based on Jackson et al. 1958 and physicians diagnosis
Occurrence of common cold (= number of subjects affected by at least one common cold episode during intervention) according to self-reporting (questionnaire based on Jackson et al. 1958) and physicians diagnosis.
Time frame: 12 weeks
Cumulative severity of common cold episodes
Cumulative severity of common cold episodes (= sum of daily symptom scores acc. to Jackson et al. 1958).
Time frame: 12 weeks
This study is completed, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Clinical Research Center Kiel GmbH